Insider Transactions in Q4 2022 at Milestone Pharmaceuticals Inc. (MIST)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2022
|
David Bharucha Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+41.18%
|
$28,000
$4.69 P/Share
|
|
Dec 01
2022
|
David Bharucha Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$12,000
$4.86 P/Share
|
|
Oct 21
2022
|
Debra K. Liebert Director |
BUY
Open market or private purchase
|
Indirect |
4,000
+50.0%
|
$20,000
$5.26 P/Share
|
|
Oct 20
2022
|
Richard C Pasternak Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$50,000
$5.2 P/Share
|
|
Oct 20
2022
|
Debra K. Liebert Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$50,000
$5.29 P/Share
|
|
Oct 19
2022
|
Robert James Wills |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$60,000
$4.93 P/Share
|
|
Oct 19
2022
|
Michael John Tomsicek |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$75,000
$5.32 P/Share
|